TNF and autoimmune hepatitis: Anti-TNF therapy-induced AIH exhibits a female predominance, a latency period of 3–14 months between the initiation of therapy and the occurrence of AIH, and shows improvement upon discontinuation of the medication along with corticosteroid use [11,97,98].